231 related articles for article (PubMed ID: 6243663)
1. New studies of the 11 beta-hydroxylase and 18-hydroxylase enzymes in the hypertensive form of congenital adrenal hyperplasia.
Levine LS; Rauh W; Gottesdiener K; Chow D; Gunczler P; Rapaport R; Pang S; Schneider B; New MI
J Clin Endocrinol Metab; 1980 Feb; 50(2):258-63. PubMed ID: 6243663
[TBL] [Abstract][Full Text] [Related]
2. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
[TBL] [Abstract][Full Text] [Related]
3. Nonsalt-losing congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency with normal glomerulosa function.
Pang S; Levine LS; Stoner E; Opitz JM; Pollack MS; Dupont B; New MI
J Clin Endocrinol Metab; 1983 Apr; 56(4):808-18. PubMed ID: 6300166
[TBL] [Abstract][Full Text] [Related]
4. The 21-hydroxylase activity in the glomerulosa and fasciculata of the adrenal cortex in congenital adrenal hyperplasia.
Kuhnle U; Chow D; Rapaport R; Pang S; Levine LS; New MI
J Clin Endocrinol Metab; 1981 Mar; 52(3):534-44. PubMed ID: 6257750
[TBL] [Abstract][Full Text] [Related]
5. The zonal origins of the mineralocorticoid hormones in the 21-hydroxylation deficiency of congenital adrenal hyperplasia.
Biglieri EG; Wajchenberg BL; Malerbi DA; Okada H; Leme CE; Kater CE
J Clin Endocrinol Metab; 1981 Nov; 53(5):964-9. PubMed ID: 6270186
[TBL] [Abstract][Full Text] [Related]
6. Combined 21- and 11 beta-hydroxylase deficiency in familial congenital adrenal hyperplasia.
Hurwitz A; Brautbar C; Milwidsky A; Vecsei P; Milewicz A; Navot D; Rösler A
J Clin Endocrinol Metab; 1985 Apr; 60(4):631-8. PubMed ID: 2982904
[TBL] [Abstract][Full Text] [Related]
7. Characterization of zona glomerulosa function in patients with classic and non-classic forms of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Castro-Magana M; Angulo M; Canas JA; Mazur B; Sarrantonio M; Vitollo P; Palekar A; Fuentes B; Lee A
J Pediatr Endocrinol Metab; 1995; 8(1):19-25. PubMed ID: 7584692
[TBL] [Abstract][Full Text] [Related]
8. Salt loss in hypertensive form of congenital adrenal hyperplasia (11-beta-hydroxylase deficiency).
Zadik Z; Kahana L; Kaufman H; Benderli A; Hochberg Z
J Clin Endocrinol Metab; 1984 Feb; 58(2):384-7. PubMed ID: 6607265
[TBL] [Abstract][Full Text] [Related]
9. The natural history of salt-wasting disorders of adrenal and renal origin.
Rösler A
J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
[TBL] [Abstract][Full Text] [Related]
10. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
Kater CE; Biglieri EG; Wajchenberg B
J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
[TBL] [Abstract][Full Text] [Related]
11. Parallelism of 11 beta- and 18-hydroxylation demonstrated by urinary free hormones in man.
Sonino N; Levine LS; Vecsei P; New MI
J Clin Endocrinol Metab; 1980 Sep; 51(3):557-60. PubMed ID: 6251104
[TBL] [Abstract][Full Text] [Related]
12. An autopsy case of 17 alpha-hydroxylase deficiency with malignant hypertension.
Morimoto I; Maeda R; Izumi M; Ishimaru T; Nishimori I; Nagataki S
J Clin Endocrinol Metab; 1983 May; 56(5):915-9. PubMed ID: 6300176
[TBL] [Abstract][Full Text] [Related]
13. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z; Benderly A; Kahana L; Zadik Z
J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
[TBL] [Abstract][Full Text] [Related]
14. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.
de Simone G; Tommaselli AP; Rossi R; Valentino R; Lauria R; Scopacasa F; Lombardi G
Hypertension; 1985; 7(2):204-10. PubMed ID: 2984117
[TBL] [Abstract][Full Text] [Related]
15. Suppression and stimulation of mineralocorticoid hormones (MCH) in the simple virilizing form of congenital adrenal hyperplasia (CAH) evaluated by the quantitation in adrenal venous blood.
Wajchenberg BL; Biglieri EG; Okada H; Malerbi DA; Achando SS; Kater CE
J Steroid Biochem; 1983 Jul; 19(1B):655-61. PubMed ID: 6350722
[TBL] [Abstract][Full Text] [Related]
16. Adrenal glomerulosa function in patients with dexamethasone-suppressible hyperaldosteronism.
Oberfield SE; Levine LS; Stoner E; Chow D; Rauh W; Greig F; Lee SM; Lightner E; Witte M; New MI
J Clin Endocrinol Metab; 1981 Jul; 53(1):158-64. PubMed ID: 7016891
[TBL] [Abstract][Full Text] [Related]
17. [Malignant arterial hypertension disclosing late congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency].
Ribstein J; Sciolla JP; Barjon P; Sultan C; Forest M; de Peretti E
Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():93-5. PubMed ID: 3142437
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
[TBL] [Abstract][Full Text] [Related]
19. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia.
Holcombe JH; Keenan BS; Nichols BL; Kirkland RT; Clayton GW
Pediatrics; 1980 Apr; 65(4):777-81. PubMed ID: 6966049
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin-aldosterone system: a long-term follow-up study in 17 alpha-hydroxylase deficiency syndrome (17OHDS).
Scaroni C; Opocher G; Mantero F
Clin Exp Hypertens A; 1986; 8(4-5):773-80. PubMed ID: 3530552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
